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Background: The pathological features of Parkinson’s disease (PD) include an abnormal accumulation of α-
synuclein in the surviving dopaminergic neurons. Though PD is multifactorial, several epidemiological reports show
an increased incidence of PD with co-exposure to pesticides such as Maneb and paraquat (MP). In pesticide-related
PD, mitochondrial dysfunction and α-synuclein oligomers have been strongly implicated, but the link between the
two has not yet been understood. Similarly, the biological effects of α-synuclein or its radical chemistry in PD is
largely unknown. Mitochondrial dysfunction during PD pathogenesis leads to release of cytochrome c in the
cytosol. Once in the cytosol, cytochrome c has one of two fates: It either binds to apaf1 and initiates apoptosis or
can act as a peroxidase. We hypothesized that as a peroxidase, cytochrome c leaked out from mitochondria can
form radicals on α-synuclein and initiate its oligomerization.
Method: Samples from controls, and MP co-exposed wild-type and α-synuclein knockout mice were studied using
immuno-spin trapping, confocal microscopy, immunohistochemistry, and microarray experiments.
Results: Experiments with MP co-exposed mice showed cytochrome c release in cytosol and its co-localization with
α-synuclein. Subsequently, we used immuno-spin trapping method to detect the formation of α-synuclein radical in
samples from an in vitro reaction mixture consisting of cytochrome c, α-synuclein, and hydrogen peroxide. These
experiments indicated that cytochrome c plays a role in α-synuclein radical formation and oligomerization. Experiments
with MP co-exposed α-synuclein knockout mice, in which cytochrome c-α synuclein co-localization and interaction
cannot occur, mice showed diminished protein radical formation and neuronal death, compared to wild-type MP co-
exposed mice. Microarray data from MP co-exposed wild-type and α-synuclein knockout mice further showed that
the absence of α-synuclein per se or its co-localization with cytochrome c confers protection from MP co-exposure,
as several important pathways were unaffected in α-synuclein knockout mice.
Conclusions: Altogether, these results show that peroxidase activity of cytochrome c contributes to α-synuclein radical
formation and oligomerization, and that α-synuclein, through its co-localization with cytochrome c or on its own,
affects several biological pathways which contribute to increased neuronal death in an MP-induced model of PD.
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Parkinson’s disease (PD) is a prominent progressive
neurological disorder with more than ten million cases
all across the globe [1]. PD involves the loss of dopamin-
ergic neurons in the substantia nigra pars compacta [2].
This degeneration is associated with motor disturbances
including tremor, rigidity, and bradikinesia [3, 4]. Al-
though the cause of sporadic PD is not fully understood,
various factors, including heavy metals and pesticides,
have been implicated [5, 6]. Epidemiological studies also
show that the risk of PD in humans is strongly increased
by combined exposure to the fungicide Maneb (manga-
nese ethylene-1,2-bisdithiocarbamate) and the herbicide
paraquat (1,1-dimethyl-4,4-bipyridinium) [7, 8]. These
two pesticides are commonly used concurrently in
agriculture. Maneb and paraquat together (MP) are well
documented as a trigger that induces the PD phenotype
in mice [3, 9]. Therefore, we used the Maneb- and
paraquat-induced PD phenotype as a model system for
our experiments.
The pathological features of PD include an abnormal
accumulation of the α-synuclein throughout various
brain regions in the remaining dopaminergic neurons
[10]. Certain mutations in SNCA (the gene which en-
codes α-synuclein) or post-translational oxidative modi-
fications have been speculated to increase the propensity
of α-synuclein to oligomerize and accumulate. Although
α-synuclein oligomers [11, 12] play crucial roles in neur-
onal regulation during PD pathogenesis, the underlying
initiating mechanism of oligomerization remains un-
known [13, 14]. We propose that α-synuclein radical
formation might be a key mechanism that initiates its
oligomerization. In one of our recent publications we
showed the formation of α-synuclein radicals in the
mid-brain of MP co-exposed mice [15]. Since MP co-
exposure is known to trigger oxidative stress by complex
1 and/or complex 3 inhibition [16], mitochondrial dys-
function [16], and NADPH oxidase activation [17, 18], a
range of possibilities existed for how α-synuclein radical
was formed. Furthermore, in pesticide-related PD, mito-
chondrial dysfunction and α-synuclein oligomers have
been strongly implicated [19, 20], but the underlying
mechanism of α-synuclein oligomerization and the link
between the two has not yet been understood. Similarly,
with the detection of α-synuclein oligomers from the brains
of PD patients, the involvement of α-synuclein in PD
pathogenesis is well established [21–23]; however, its role
in the disease process and its effects on critical cellular
pathways which contribute to neuronal death remain un-
known. There is considerable evidence that free radicals,
mitochondrial dysfunction, and α-synuclein oligomerization
play roles in the pathogenesis of PD [21, 22, 24–26]. Within
dopaminergic neurons, mitochondria are in peril of damage
from reactive oxygen species generated by disruption of theelectron transport chain or autoxidation of dopamine
[20, 27]. Damage to presynaptic mitochondria, caused
by environmental insults such as pesticides, results in
the release of cytochrome c. Once in the cytosol,
cytochrome c has one of two fates: It either binds to
apaf1 and initiates the apoptotic cascade or can act as a
peroxidase [28]. This peroxidase activity of cytochrome c
is triggered either through cleavage of methionine-80 from
heme iron by action of proteolytic enzymes present in
cytosol or through its oxidation [29–32]. Theoretically,
cytochrome c as a peroxidase can form radicals on pro-
teins in proximity using hydrogen peroxide as a substrate
[29, 33, 34]. As one of the most abundant proteins in the
terminals of dopaminergic neurons, α-synuclein in the
presence of anionic phospholipids can easily divert cyto-
chrome c and, hence, prevent binding of cytochrome c to
apaf1 [35–38]. In addition, α-synuclein has a very high
affinity for anionic phospholipids such as phosphatidylser-
ine, and these lipids can facilitate its crosslinking to
cytochrome c [28, 39].
Owing to reports showing co-localization of cyto-
chrome c and α-synuclein in the brains of PD patients
[28], we hypothesized the role of cytochrome c as a
peroxidase in α-synuclein radical formation. Altogether,
we aimed to investigate (I) a possible correlation
between mitochondrial dysfunction concurrent with
cytochrome c release and the role of cytochrome c in α-
synuclein radical formation, (II) the role of cytochrome c
in α-synuclein oligomerization, and (III) the biological
implications of α-synuclein radical formation or the role
of α-synuclein per se in terms of its effects on biological
pathways and neuronal death.
Here we report for the first time that cytochrome c
plays a crucial role in α-synuclein radical formation and
oligomerization and that α-synuclein radical formation
or α-synuclein per se significantly affects several bio-
logical pathways, which ultimately contributes to neur-
onal death in the MP-induced mouse model of PD. This
understanding will be fundamental to determine the role
of peroxidase chemistry in PD pathogenesis. Under-
standing cytochrome c-mediated α-synuclein radical
formation and its aftereffects in a pesticide-induced
model of PD will provide new insights into the role of
protein radicals and α-synuclein in PD pathogenesis.
Methods
Chemicals
Cytochrome c, Maneb (Manganese ethylene-1,2-bisdithio-
carbamate), paraquat (1,1-dimethyl-4,4-bipyridinium), para-
formaldehyde, recombinant α-synuclein, Triton X-100, and
TRI Reagent were from Sigma (St. Louis, MO). 5, 5-
dimethyl-1-pyrroline N-oxide (DMPO) was obtained from
Dojindo Laboratories (Rockville, MD) and used without
further purification. Chicken polyclonal and mouse
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our laboratory and used in the immuno-spin trapping
studies. Rabbit polyclonal anti-tyrosine hydroxylase anti-
body was from Millipore (Billerica, MA). Rabbit anti-α-
synuclein, mouse anti-cytochrome c, anti-complex IV,
anti-caspase-3, anti-caspase-9 and anti-β-actin antibodies
were from Abcam (Cambridge, MA). Micro BCA Protein
Assay Kit, Permount, RIPA buffer, Surfact-Amps X-100,
Mitochondria Isolation Kits for Tissue, and Pierce Classic
Immunoprecipitation Kits were from Thermo Scientific
(Rockford, IL). Nitrocellulose membranes, Prolong Gold
anti-fade reagent with DAPI and AlexaFluor secondary
antibodies were from Invitrogen (Grand Island, NY). The
Vectastain Elite ABC kit for immunohistochemistry was
from Vector Laboratories (Peterborough, UK). RNeasy
mini kit columns were from Qiagen (Valencia, CA).
Agilent Whole Mouse 4X44K microarray slides and the
reagents used in microarray experiments were all from
Agilent Technologies (Santa Clara, CA).
Animal treatment
Adult (8-10-week-old), pathogen-free male mice (C57BL6/
J from Jackson Laboratories, Bar Harbor, ME) were housed
one to a cage for a week for acclimatization before experi-
mental dosing. Mice that contained disrupted α-synuclein
(α-synuclein knockout mice, stock number 003692) were
treated similarly. Age-matched, wild-type C57BL6/J mice
that contained α-synuclein served as the control animals
for knockout experiments. The animals were housed
under standard conditions of temperature and humidity
with a 12 h light/dark cycle and fed a standard pellet diet
and water ad libitum. Animals were treated with normal
saline (control), paraquat (10 mg/kg, ip) and Maneb
(30 mg/kg, ip) twice a week for 6 weeks. A minimum of
3–5 animals were used per group for Western blot, immu-
nohistochemical, and confocal studies. All animals were
treated in strict accordance with the NIH Guide for the
Care and Use of Laboratory Animals, and the animal study
proposal was approved by the NIEHS ASP review board.
In vivo immuno-spin trapping studies
DMPO was administered at a dose of 2 g/kg, ip, two
hours after the final dose of MP at the 6-week time
point in a set of animals in which protein radical detec-
tion experiments were performed. Animals were sacri-
ficed 2 h after DMPO injection, and sections/samples
were used for confocal microscopy and immunoprecipi-
tation experiments to detect α-synuclein radicals.
Confocal microscopy of brain tissue
Cryocut sections (30 μm thick) were collected and
standard staining protocols were used as published earl-
ier [15]. In brief, tissue slices were permeabilised (0.2%
Surfact-Amps X-100 in PBS) for 5 min and blockedovernight and then incubated for 2 h with the primary
anti-DMPO (1:2,000) and/or anti-α-synuclein (1:2,000)
and/or anti-cytochrome c (1:2000) and anti-tyrosine hy-
droxylase antisera (1:4,000), followed by incubation with
secondary Alexa Fluor antisera diluted 1:1,000 for an
hour. Slides were washed, dried and mounted using
Prolong Gold anti-fade reagent with DAPI. Confocal im-
ages were taken on a Zeiss LSM 710-UV meta micro-
scope (Carl Zeiss Inc. Oberkochen, Germany) using a
Plan-NeoFluar 40X/1.3 Oil DIC objective.
Immunoprecipitation and Western blot analysis
Immunoprecipitation of α-synuclein adducted to DMPO
from nigrostriatal tissue homogenates was carried out
with the Pierce Classic Immunoprecipitation Kit using a
standard protocol as described elsewhere [15]. For
Western blot, standard protocols were followed with the
use of mouse monoclonal anti-DMPO antibody (1:250)/
anti- α-synuclein antibody (1:3000)/anti-tyrosine hydroxy-
lase antibody (1:4,000)/ anti-cytochrome c (1:4000)/anti-β
-actin antibodies (1:4,000), and bands were detected using
the appropriate fluorescent secondary antibody (1:10,000,
diluted in washing buffer) labeled with infrared dyes. An
Odyssey infrared imaging system (Li-Cor Biosciences,
Lincoln, NE) was used to acquire the images. For Western
blotting of cytochrome c, we isolated mitochondrial and
cytosolic fractions using a Thermo Scientific Mitochondria
Isolation Kit for Tissue with the standard Dounce
homogenization and differential centrifugation method.
The resulting mitochondrial and cytosolic fractions were
analyzed by Western blot for cytochrome c and complex
IV. A Western blot for complex IV, which is a mitochon-
drial marker, was used to rule out any possible traces of
mitochondria in the cytosolic fraction.
Chemical reactions
Typically, a reaction mixture of 1.5 μM α-synuclein,
0.5 μM cytochrome c, 50 mM DMPO and hydrogen
peroxide in 100 mM Chelex-treated sodium phosphate
buffer (pH 7.4) with 25 μM DTPA in a total volume of
200 μl was incubated for 1 h at 37 °C. Samples were di-
luted and used for electrophoresis and immuno-spin
trapping experiments using an anti-DMPO antibody
(Fig. 3a). This reaction mixture was also analyzed using
cytochrome c and α-synuclein antibody to test the
oligomerization of α-synuclein (Fig. 3b).
Immunohistochemistry
For immunohistochemistry of tyrosine hydroxylase
(TH), mice were anesthetized and perfused transcardially
with 4% paraformaldehyde. Perfused mouse brains were
excised, post-fixed overnight at 4 °C, and cryoprotected
in sucrose (10–30%). Serial coronal sections (30 μm
thick) were collected to ensure capture of the entire SN/
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standard protocol [40]. The sections were mounted
using Permount, and images were captured with a bright
field microscope at 8× magnification. Coded slides were
used, and counting was performed independently to en-
sure unbiased counting of TH-positive neurons in every
3rd serial section. TH-positive neurons were counted
and analyzed bilaterally using a Metamorph image
analysis tool [15]. A minimum of five animals per
group were used for counting TH-immunoreactive
neurons.Global gene expression by microarray and bioinformatics
data analyses
Total RNA was isolated from the nigrostriatal tissue of
three independent triplicates using the TRIzol (Ambion,
Life Technologies, Grand Island, NY) and RNeasy mini
kit columns with in-column DNAse treatment (Qiagen,
Valencia, CA). Gene expression analysis was conducted
using Agilent whole mouse Genome 4x44 multiplex ar-
rays (Product # G4846A, Agilent Technologies, CA).
Total purified RNA samples were labelled with Cy3 ac-
cording to the manufacturer’s protocol. Initial data were
obtained using the Agilent Feature Extraction software
(v. 12) and further processed using R (version 3.1.3) and
RStudio (version 0.98.1103). Raw microarray data was
normalized, and the background was subtracted using
the limma package (version 3.22.6). Principal component
analyses were performed. Gene annotation was per-
formed using the database mgug4122a.db. Differential
expression was evaluated. Weighted Venn diagrams were
drawn using the Venn diagram package (version 1.6.0).
Heatmaps were prepared using the gplot package (ver-
sion 2.16.0). Two different 2-contrast GSEA analyses
were conducted: 1. MP-treated versus control; 2. MP-
treated α-synuclein knockout versus control mice. GSEA
analyses were performed using the full table of anno-
tated genes (log transformed intensities) with the hall-
mark database, h.all.v5.0.symbols, 1,000 permutations,
and defaults for other parameters. Only gene sets with
normalized p-value (NORM p-val) lower than 0.05 and
false discovery rate (FDR q-val) lower than 0.25 were
considered enriched.Statistical analyses
All animal experiments were repeated at least three
times with a minimum of 3–5 mice per group (n = 3–5).
One-way analysis of variance (ANOVA) was used for
statistical analysis. The Newman–Keuls Post-Test was
used for multiple comparisons. The results are expressed
as mean ± SEM. The differences were considered statisti-
cally significant at p < 0.05.Results
Maneb and Paraquat co-exposure induces α-synuclein
radical formation in dopaminergic neurons of exposed
mice
Immuno-spin trapping experiments (Additional file 1:
Scheme S1) in conjunction with confocal microscopy
with the midbrain sections of MP co-exposed mice
showed anti-DMPO staining and its co-localization
with α-synuclein and tyrosine hydroxylase, which is a
marker enzyme for dopaminergic neurons (Fig. 1a).
This result indicated that protein radicals were formed
within dopaminergic neurons and perhaps on α-
synuclein. To test for α-synuclein radical formation, α-
synuclein was immunoprecipitated from nigrostriatal
tissue homogenates of controls and MP co-exposed
mice and probed with anti-DMPO antibody (Fig. 1b)
and anti- α-synuclein antibody (Fig. 1c). Proteins
immunoprecipitated with normal mouse IgG did not
show either detectable DMPO adducts (lane 1, Fig. 1b)
or α-synuclein (lane 1, Fig. 1c). α-Synuclein was de-
tected in immunoprecipitates from both control and
MP co-exposed groups (lanes 2 and 3, Fig. 1c); however,
an anti-DMPO-positive band on the immunoprecipi-
tated α-synuclein (lane 3, Fig. 1b) was present only in
the MP co-exposed group. This further indicates that
MP co-exposure led to α-synuclein radical formation in
dopaminergic neurons. Having confirmed that MP co-
exposure led to α-synuclein radical formation, we
further investigated its possible correlations with perox-
idase function of cytochrome c, which typically comes
out in cytoplasm after some extent of mitochondrial
damage [9, 41].Cytochrome c and α-synuclein co-localization
Mitochondrial damage/dysfunction is often associated
with cytochrome c release in cytoplasm; therefore, cyto-
chrome c levels were analyzed by Western blotting,
which showed increased levels of cytochrome c in the
cytosolic fraction of nigrostriatal tissue of MP co-
exposed mice (Fig. 2a). Subsequent confocal microscopy
experiments showed co-localization of cytochrome c
with α-synuclein in the mid-brain of MP co-exposed
mice (Fig. 2b). These results were consistent with cyto-
chrome c leaking out into the cytosol and co-localizing
with α-synuclein. Cytochrome c acting as a peroxidase
may form radicals on proteins in its proximity. Based on
the cytochrome c-α-synuclein co-localization, the known
peroxidase activity of cytochrome c in the cytoplasm,
and the presence of hydrogen peroxide as a peroxidase
substrate in dopaminergic neurons of MP co-exposed
mice, we decided to further investigate the possible role
of cytochrome c in α-synuclein radical formation using a
pure in vitro system.
Fig. 2 Western blot of cytochrome c with respective constitutive proteins from (a) mitochondrial and (b) cytosolic fraction of nigrostriatal tissue
of control and MP co-exposed mice. c Confocal images showing the co-localization of cytochrome c and α-synuclein in mid-brain slices of control
and MP co-exposed mice. Blots or images are representative of four different immunoblots from an equal number of experiments
Fig. 1 Detection of α-synuclein-centered radicals in tyrosine hydroxylase positive neurons. a Confocal images of mid-brain sections from sham+DMPO
(control) and MP+DMPO-treated mice showing the co-localization of anti-DMPO, α-synuclein and tyrosine hydroxylase. b Immunoprecipitation of
DMPO adducts from nigrostriatal tissue homogenates of control (lane 1 and 2) and MP co-exposed (lane 3) mice. Proteins were immunoprecipitated
from nigrostriatal tissue homogenates using either normal mouse IgG (lane1) or with anti-α-synuclein antibody (lane 2 and 3) followed by Western
blotting of immunoprecipitates using rabbit polyclonal anti-DMPO antibody. c Proteins were immunoprecipitated from nigrostriatal tissue homogenates
as in figure B, followed by Western blotting of immunoprecipitates using rabbit polyclonal anti-alpha-synuclein antibody. Blots are representative of four
different immunoblots from an equal number of experiments
Kumar et al. Molecular Neurodegeneration  (2016) 11:70 Page 5 of 12
Kumar et al. Molecular Neurodegeneration  (2016) 11:70 Page 6 of 12Cytochrome c as a peroxidase induces α-synuclein radical
formation and oligomerization
To investigate the role of cytochrome c in α-synuclein
radical formation, an in vitro reaction mixture was used.
The reaction mixture contained α-synuclein (1.5 μM),
cytochrome c (0.5 μM), and DMPO (50 mM) in the
presence and absence of hydrogen peroxide (0, 25–
50 μM), and was incubated at 37 °C for 1 h in chelexed
phosphate buffer with DTPA (25 μM). Samples were
then used for immuno-spin trapping experiments using
an anti-DMPO antibody and results indicated protein
radical formation on α-synuclein and to a much lesser
extent on cytochrome c (Fig. 3a). The dependence of
radical formation on hydrogen peroxide indicated the
role of cytochrome c as a peroxidase in α-synuclein for-
mation. Subsequent experiments showed that conditions
similar to those that led to protein radical formation on
α-synuclein also led to oligomerization of α-synuclein
(Fig. 3b). Interestingly, oligomerization of α-synuclein
was not seen when cytochrome c was absent in the reac-
tion mixture. Together, these results showed the role of
cytochrome c as a peroxidase in α-synuclein radical
formation and oligomerization. Owing to the higherFig. 3 a Anti-DMPO Western blotting showing α-synuclein radical
formation. The reaction mixture containing α-synuclein (1.5 μM),
cytochrome c (0.5 μM), and DMPO (50 mM) in the presence and
absence of various concentrations of hydrogen peroxide (0, 25,
50 μM) was incubated at 37 °C for 1 h in chelexed phosphate buffer
with 25 μM DTPA in a total volume of 200 μl. Samples were then used
for electrophoresis and immuno-spin-trapping experiments using an
anti-DMPO antibody. b Western blotting showing oligomerization of
α-synuclein using the same reaction mixture and conditions as in Aavailability of the peroxidase substrate hydrogen perox-
ide in dopaminergic neurons of MP co-exposed mice,
these results indicate the important role of cytochrome c
as a peroxidase in PD pathogenesis.
α-Synuclein plays a key role in protein radical formation
in dopaminergic neurons
After confirming protein radical formation on α-synuclein
(α-synuclein radical) and elucidating the underlying mech-
anism of its formation, we further analyzed the role of α-
synuclein in overall protein radical formation in the
dopaminergic neurons of MP co-exposed mice. In order
to ascertain the role of α-synuclein, α-synuclein knockout
mice were co-exposed to MP for 6 weeks and then ana-
lyzed using immuno-spin trapping [42]. Immuno-spin
trapping experiments in conjunction with confocal mi-
croscopy of mid-brain sections of MP co-exposed mice
showed intense anti-DMPO staining, which indicates pro-
tein radical formation. Furthermore, experiments with MP
co-exposed α-synuclein knockout mice showed dimin-
ished protein radical formation compared to wild-type
MP co-exposed mice (Fig. 4a, b). These results indicated
the role of α-synuclein in overall protein radicalFig. 4 Protein radical formation in the midbrain of mice after 6 weeks
of Maneb (30 mg/kg, i.p.) and paraquat (10 mg/kg, i.p.) co-exposure.
a Confocal images showing anti-DMPO staining in mid-brain slices of
Maneb and paraquat co-exposed mice. b Fluorescence intensity
quantification of anti-DMPO staining
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α-synuclein co-localization cannot occur, and in that case
cytochrome c may support apoptosis instead of acting as a
peroxidase and contributing to protein radical formation.
This was one possible explanation of the diminished pro-
tein radical formation in MP co-exposed α-synuclein
knockout mice; however, to get a clear picture of what is
different in α-synuclein knockout mice, we further investi-
gated its effects on biological pathways using microarrays.
Microarray analysis shows diminished biological effects of
MP in α-synuclein knockout mice
Analyses of variance for global gene expression of
nigrostriatal tissue showed that MP co-exposure to wild-
type animals, which have α-synuclein, induced a massive
change in global gene expression (Fig. 5a); in contrast, in
nigrostriatal tissue of α-synuclein knockout animals MP
treatment induced only minor changes in global gene
expression. Genes differentially expressed (p-values
lower than 0.05) in wild-type animals co-exposed with
MP were more than 94% of all genes differentially
expressed, while less than 10% of all differentially
expressed genes were altered in the α-synuclein knock-
out animals (Fig. 5b). GSEA analyses of microarray data
showed major changes in 13 gene sets under the same
conditions as those that produced α-synuclein radical
formation in wild-type MP co-exposed mice (Fig. 5c).
These gene sets were related to the hallmark pathways
of MYC targets, hypoxia, TNF α signaling, xenobiotic
metabolism, E2F targets, apoptosis, inflammation, DNA
repair, JAK-STAT3 signaling, bile acid metabolism, heme
metabolism, the P53 pathway, and glycolysis (Additional
file 1: Figure S1A-S1J). We show heatmaps for the ex-
pression levels of several genes that play important roles
in xenobiotic metabolism, inflammation and apoptosis
(Fig. 5d–f ). Simultaneously, MP co-exposed α-synuclein
knockout mice showed decrease in genes of only two
pathways (Interferon α and Interferon Gamma) after the
same MP co-exposure regimen as in wild type mice.
Since these pathways were downregulated, it was appar-
ent that these changes were also protective in nature
(Fig. 5c). Altogether, these results indicate that the
absence of α-synuclein per se or α-synuclein radical for-
mation diminished the biological effects on several path-
ways that contribute to increased free radical generation
and neuronal death.
Maneb and paraquat co-exposure-induced neuronal
death is diminished in α-synuclein knockout mice
To further investigate the role of radical chemistry and
the effects of α-synuclein radical formation on neuronal
death, tyrosine hydroxylase immunoreactivity was inves-
tigated. After 6 weeks of exposure, we observed a signifi-
cant decline in tyrosine hydroxylase immuno-reactivityand the number of TH-positive neurons in the substan-
tia nigra pars compacta in the brains of wild-type mice.
The absence of α-synuclein conferred neuroprotection
with diminished neuronal death induced by MP co-
exposure in α-synuclein knockout mice (Fig. 6a–c). This
concurrence between neuronal death and protein radical
formation (Fig. 4a, b) and its reliance on α-synuclein, as
evident with diminished neuronal death and protein rad-
ical formation in MP co-exposed α-synuclein knockout
mice, indicates an important role of α-synuclein in the
neuronal death process.Discussion
Based on our previous published work [15] and results
presented here, we report that there are two distinct
mechanisms which can lead to α-synuclein radical for-
mation. One is α-synuclein radical formation through
NADPH oxidase activation and peroxynitrite formation,
and the other is through peroxidase activity of cyto-
chrome c. Since MP co-exposure leads to both NADPH
oxidase activation and mitochondrial dysfunction, both
pathways can lead to α-synuclein radical formation.
However, the fact remains that both pathways are dis-
tinct because radical formation through NADPH oxidase
is mediated by peroxynitrite, mostly diffusing out from
microglia [15], whereas, cytochrome c mediated α-
synuclein radical formation starts from leaky mitochon-
dria within dopaminergic neurons.
As one of the most abundant proteins in the terminals
of dopaminergic neurons, α-synuclein in the presence of
anionic phospholipids can easily divert cytochrome c and,
hence, prevent binding of cytochrome c to apaf1 [35]. α-
Synuclein has a very high affinity for anionic phospho-
lipids such as phosphatidylserine, and these lipids can
facilitate its cross linking to cytochrome c [28, 39]. The
cross-linking of α-synuclein to cytochrome c in the cytosol
delays initiation of apoptosis in neurons [28]. Because
cytochrome c-dependent formation of apoptosomes and
activation of caspases designates a point of no return in
the apoptotic program, the interaction of cytochrome c
with α-synuclein after its release from mitochondria con-
fers immediate protection. However, this vital function of
diverting cytochrome c from initiating apoptosis is accom-
panied by the emergence of peroxidase activity of the
cytochrome c. Thus, protection against acute apoptotic
cell death comes with a penalty: the formation of a
complex (cytochrome c and α-synuclein) with persistent
peroxidase activity which can further affect proteins
such as α-synuclein as well as others. Theoretically,
peroxidase-induced protein radical formation should
not be limited only to α-synuclein, but rather to a
large extent depends on the protein’s concentration,
affinity or proximity to cytochrome c, presence of
Fig. 5 Microarray analysis of nigrostriatal tissue of MP co-exposed wild type and α-synuclein knockout mice. a Graph showing nearly similar gene
expression pattern of wild-type sham-treated mice and α-synuclein knockout mice co-exposed to MP for 6 weeks. b Weighted Venn diagram for
total number of genes with significantly different expression values (p-value lower than 0.05) in nigrostriatal tissue of treated animals compared
to wild-type controls. c Upper panel showing upregulation of 13 pathways in wild type MP co-exposed mice compared to wild type sham-
treated mice; lower panel showing downregulation of 2 pathways in MP co-exposed α-synuclein knockout mice compared to wild-type sham-
treated mice. Heat maps for all these pathways are shown in Additional file 1: Figure S1. d Heat map showing changes in expression of hallmark
genes in the xenobiotic metabolism pathway. e Heat map showing changes in expression of hallmark genes in the apoptotic pathway. f Heat
map showing changes in expression of hallmark genes in the inflammatory response pathway. ES stands for Enrichment Score, and NES stands
for Normalized Enrichment Score
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Fig. 6 Tyrosine hydroxylase (TH) immunoreactivity in the substantia nigra of mouse brains after 6 weeks of MP co-exposure. a TH immunoreactivity in
frozen brain sections of controls, MP co-exposed wild type, and MP co-exposed α-synuclein knockout mice. b Number of TH positive neurons in the
substantia nigra pars compacta (SNPC) region of all experimental groups as in a. c Western blot analysis of TH protein in the nigrostriatal tissue of
mouse brains following 6 weeks of Maneb and paraquat co-exposure. *p-value < 0.05, ***p-value < 0.001 as compared with control and #
p-value < 0.05 as compared with the MP co-exposed group
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peroxidase substrates [28, 29, 39, 43].
For cytochrome c to work as a peroxidase, it must leak
out into the cytoplasm, where it gets activated by oxida-
tion or cleavage of its methionine residue by action of the
proteolytic enzymes present in the cytosol [28, 31]. This
cytochrome c that can work as a peroxidase in cytoplasm
was co-localized with α-synuclein in mid-brain slices of
MP co-exposed mice (Fig. 2). To further investigate the
mechanism and confirm the role of cytochrome c in α-
synuclein radical formation, we used an analogous in vitro
system that co-incubated cytochrome c, α-synuclein and
hydrogen peroxide. Based on the in vitro results, we in-
ferred that cytochrome c as a peroxidase can form radicals
on α-synuclein (Fig. 3a). Owing to the presence of
oxidizable residues [21, 44] (tyrosine, cysteine and histi-
dine) [45] on α-synuclein, it is highly likely that similar
chemistry takes place in the dopaminergic neurons of MP
co-exposed mice, due in part to the higher abundance of
peroxidase substrates in dopaminergic neurons.
Several groups have reported that, physiologically, α-
synuclein exists almost exclusively in its unfolded mono-
meric form, and oligomeric forms are mostly associated
with diseases [19, 46]. Biochemical measurements of α-
synuclein isolated from brains of PD patients revealed the
presence of covalently linked α-synuclein oligomers [47],
but what triggers this covalent oligomerization had notyet been understood. Therefore, we further investigated
the oligomerization of α-synuclein in the presence and ab-
sence of cytochrome c and hydrogen peroxide and found
that α-synuclein radical formation and oligomerization
was taking place concurrently (Fig. 3b). This can be ex-
plained in the light of the fact that a protein as a free rad-
ical can serve as an initiating mechanism for dimerization
or can simply form dimers with another protein radical.
Reports in the literature show that α-synuclein has four
tyrosine residues [48], and formation of tyrosyl radicals is
well known to lead to radical-radical recombination to
form dityrosine and, thereby, dimer formation [21]. These
reports support our present data that cytochrome c in the
presence of hydrogen peroxide is capable of forming di-
mers of α-synuclein through radical-radical dimerization.
Also radical formation on α-synuclein can alter the orien-
tation of hydrophobic moieties of α-synuclein, and that
can make the protein sticky and promote its aggregation
[45]. Furthermore, radical formation on cytochrome c,
though to a lesser extent (Fig. 3a), and its oligomerization
(Fig. 3b), is in accordance with reports in which authors
have shown oxidative modifications and oligomerization
of cytochrome c by hydrogen peroxide [49]. In addition,
cytochrome c has also been documented to show proper-
ties of self-association and oligomerization [50], which
might be another reason for cytochrome c oligomerization
in our experimental set up (Fig. 3b).
Scheme 1 Role of cytochrome c as peroxidase in α-synuclein radical
formation and oligomerization
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radical formation and oligomerization, we further investi-
gated the role of α-synuclein in overall protein radical for-
mation using α-synuclein knockout mice. A significant
decline in overall protein radical formation as evidenced
by the diminished intensity of anti-DMPO in α-synuclein
knockout mice was due to the fact that in knockout mice,
cytochrome c-α-synuclein co-localization can’t occur.
The absence of co-localization actually diverts cyto-
chrome c into the apoptotic pathway, and then it no
longer contributes to protein radical formation. This is
one possible explanation of diminished protein radical
formation in MP co-exposed α-synuclein knockout
mice; however, microarray data indicated that α-
synuclein crucially affects several pathways which may
contribute to diminished protein radical formation in
MP co-exposed knock out mice.
Microarray analysis showed that in wild-type MP co-
exposed mice where α-synuclein was present, 13 important
biological pathways were upregulated. However, in α-
synuclein knockout mice, MP co-exposure could elicit
downregulation of only two pathways (Fig. 5c). These re-
sults support the importance of α-synuclein in animal
models of PD, and PD pathogenesis in general. Although
thirteen (Additional file 1: Figure S1A–S1K) pathways
showed significant changes, we focused our attention on
xenobiotic metabolism, inflammatory response and apop-
totic pathways (Fig. 5d–f). These pathways were upregu-
lated only in animals with α-synuclein. Since these
pathways rely on or contribute to free radical generation
[22, 45], we can further corroborate the role of α-synuclein
in overall protein radical generation and PD pathogenesis.
Furthermore, Western blots for caspase-9 and cleaved
caspase-3 (Additional file 1: Figure S2) indicated that the
extent of apoptosis is certainly high in MP co-exposed
mice. However, it was close to control levels in MP co-
exposed α-synuclein knockout mice. These results are con-
sistent with microarray data in Fig. 5e, in which it is shown
that while the overall gene expression pattern of “hallmark
of apoptosis genes” is similar between the controls and MP
co-exposed α-synuclein knockout mice, it is significantly
higher in MP co-exposed wild-type mice. These results ap-
peared to be in line with previous reports, which showed
that α-synuclein protects neurons from apoptosis down-
stream of free-radical production through modulation of
the MAPK signaling pathway [51]. As shown by Bayir
et al., [28] and in this manuscript, α-synuclein diverts cyto-
chrome c from the initial acute apoptosis. However, this
immediate protection comes with the formation and accu-
mulation of α-synuclein oligomers (Scheme 1). As shown
by several investigators, these oligomers can further impair
several important rescue processes like autophagy [52, 53]
and make cells more prone to accumulate damage. This
eventually leads to delayed apoptosis, and that is why wesee upregulation of markers of apoptosis in wild type mice
after chronic MP co-exposure for 6 weeks. Typically, Par-
kinson’s disease is characterized by slow and progressive
neuronal death, therefore the cytochrome c- and α-
synuclein-mediated process of accumulating damage and
conferring delayed apoptosis makes better sense in the dis-
ease context. This explanation is further supported by the
fact that the absence of α-synuclein in knockout mice con-
fers protection against chronic MP co-exposure (Fig. 6a–c)
[54, 55]. These results appear to be in line with another
study in which mice lacking α-synuclein showed decreased
loss of striatal dopamine following prolonged chronic
MPTP administration [23].Conclusion
In summary, this study provides evidence for the first
time that cytochrome c as a peroxidase plays a role in α-
synuclein radical formation and oligomerization. Also,
through various lines of evidence, this study demon-
strates the involvement of α-synuclein in overall protein
radical formation, alterations in several biological path-
ways and dopaminergic neuronal death. Altogether, the
detection of α-synuclein radicals and understanding the
underlying involvement of cytochrome c as a peroxidase
in PD pathogenesis will expand our current knowledge
about the mechanistic aspects of PD.
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Additional file 1: This contains Figure S1, S2, Scheme S1. Figure S1
contains heat maps showing changes in gene expression as mentioned in
Fig. 5c. Figure S2 shows Western blots for α-synuclein, caspase-9, and
cleaved caspase-3. Scheme S1 shows an outline of immuno-spin trapping
method in which anti-DMPO antibody is used to detect protein radicals.
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